Your trusted source for investing success
The biotech sector has steadily enjoyed an increase this year, in part thanks to significant advancements and in spite of the uncertainty from the White House as the proposal of a new healthcare bill holds the grip of most life science markets.
Nabriva Therapeutics plc saw its stock get a major boost on Monday morning after the company announced top-line results from their trial of a pneumonia drug.
Tetra Bio-Pharma announces that it will be filing a clinical trial application in the coming weeks to therapeutic products directorate to initiate its Phase 3 clinical trial of PPP001 in terminal cancer patients.
By Shelly Kumar
DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI), a biopharmaceutical company focused on the development of new cancer therapies, today announced that the U.S. Food and Drug Administration (“FDA”) has allowed an additional Investigational New Drug Application (“IND”) to study its lead drug candidate VAL-083 as a potential treatment for ovarian cancer.
“The opening of this
CASI Pharmaceuticals, Savara, Adverum Biotechnologies, ChromaDex Therapeutics and MannKind top the NASDAQ biotech stock list.
The Investing News rounds some of the biggest news in the cannabis market for the past trading week
Soleno Therapeutics presented new efficacy data from the pilot clinical trial of Diazoxide Choline Controlled-Release Tablet treating Prader-Willi syndrome at the International Meeting of Pediatric Endocrinology.
Daxor announced it will be exhibiting at an upcoming heart medical conference.
The global stem cell therapy market is expected to grow at a CAGR of 36.52 percent between 2017 and 2021. Here are 10 top stem cell companies on the NASDAQ.
By Melissa Shaw
Canadian researchers say there could be up to $7 billion worth of nickel contained within tailings from mines in Sudbury, Ontario.
The medical device industry is robust and diverse. Here are four small medical device companies that investors should watch.
Soleno Therapeutics announced the issuance of a new US patent from the related to the use of pharmaceutical formulations of diazoxide and its salts.
By Shelly Kumar
Lomiko Metals Inc. (TSXV:LMR,OTCQX:LMRMF,FSE:DH8B) announces that its Board of Directors (the “Board”) has approved the renewal of the shareholder rights plan (the “Plan”) which was ratified at its annual and special meeting of the shareholders on October 30, 2014. The Plan had an initial term which will expire at the
Helius Medical Technologies announced its subsidiary NeuroHabilitation executed an extension to its research and development agreement with the US Army Medical Research and Materiel Command through 2018.
Moleculin Biotech engaged a contract research organization Bioscience, to prepare for a proof-of-concept clinical trial in Poland to study its drug candidate WP1220 for the treatment of cutaneous T-cell lymphoma.
BioCorRx announced the completion and beta launch of its proprietary mobile application for use by licensed behavioral specialists and individuals in treatment for opioid and alcohol use disorders.
Ironbark Zinc Limited (“Ironbark”) (ASX: IBG) is pleased to provide results from the Feasibility Study Update
of Ironbark’s 100% owned Citronen Project.
As quoted in the press release:
Commenting on the results of the updated cost evaluation of the Feasibility Study Ironbark Managing Director Jonathan Downes said: “We are extremely pleased with the
Heat Biologics announced it will hold a Type C meeting with the US Food and Drug Administration for the roadmap of their non-small cell lung cancer trial.
Major players in the pharmaceutical industry include Johnson & Johnson, Novartis, Roche, Pfizer and Merck.
By Siv Padhy
Lithium production numbers are often broken down in terms of lithium carbonate equivalent. But what is lithium carbonate? Find out here.
